These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 10397328)
1. CD79a detected by ZL7.4 separates chronic lymphocytic leukemia from mantle cell lymphoma in the leukemic phase. Bell PB; Rooney N; Bosanquet AG Cytometry; 1999 Jun; 38(3):102-5. PubMed ID: 10397328 [TBL] [Abstract][Full Text] [Related]
2. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia. Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971 [TBL] [Abstract][Full Text] [Related]
3. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders. Cabezudo E; Carrara P; Morilla R; Matutes E Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919 [TBL] [Abstract][Full Text] [Related]
4. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL. Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689 [TBL] [Abstract][Full Text] [Related]
5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [TBL] [Abstract][Full Text] [Related]
6. CD23 expression in transformed small lymphocytic lymphomas/chronic lymphocytic leukemias and blastic transformations of mantle cell lymphoma. Dunphy CH; Wheaton SE; Perkins SL Mod Pathol; 1997 Aug; 10(8):818-22. PubMed ID: 9267825 [TBL] [Abstract][Full Text] [Related]
7. Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia/small lymphocytic lymphoma. Gong JZ; Lagoo AS; Peters D; Horvatinovich J; Benz P; Buckley PJ Am J Clin Pathol; 2001 Dec; 116(6):893-7. PubMed ID: 11764079 [TBL] [Abstract][Full Text] [Related]
8. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment. Kusenda J; Babusíková O Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418 [TBL] [Abstract][Full Text] [Related]
9. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases. Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002 [TBL] [Abstract][Full Text] [Related]
10. Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukaemia and mantle cell lymphoma cells: relationship to ex vivo chemoresponse. Bosanquet AG; Bell PB; Rooney N Anticancer Res; 1999; 19(6B):5329-34. PubMed ID: 10697557 [TBL] [Abstract][Full Text] [Related]
11. Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23. Dorfman DM; Pinkus GS Mod Pathol; 1994 Apr; 7(3):326-31. PubMed ID: 8058704 [TBL] [Abstract][Full Text] [Related]
12. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL). Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous intracellular expression of B-cell receptor components in B-cell chronic lymphocytic leukaemia (B-CLL) cells and effects of CD79b gene transfer on surface immunoglobulin levels in a B-CLL-derived cell line. Minuzzo S; Indraccolo S; Tosello V; Piovan E; Cabrelle A; Trentin L; Semenzato G; Amadori A Br J Haematol; 2005 Sep; 130(6):878-89. PubMed ID: 16156858 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of CD79b expression in the diagnosis of B-cell chronic lymphoproliferative disorders. McCarron KF; Hammel JP; Hsi ED Am J Clin Pathol; 2000 Jun; 113(6):805-13. PubMed ID: 10874881 [TBL] [Abstract][Full Text] [Related]
16. Leukemic phase of B-cell lymphomas mimicking chronic lymphocytic leukemia and variants at presentation. Nelson BP; Variakojis D; Peterson LC Mod Pathol; 2002 Nov; 15(11):1111-20. PubMed ID: 12429788 [TBL] [Abstract][Full Text] [Related]
17. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797 [TBL] [Abstract][Full Text] [Related]
18. Expression of thrombospondin receptor (CD36) in B-cell chronic lymphocytic leukemia as an indicator of tumor cell dissemination. Rutella S; Rumi C; Puggioni P; Barberi T; Di Mario A; Larocca LM; Leone G Haematologica; 1999 May; 84(5):419-24. PubMed ID: 10329920 [TBL] [Abstract][Full Text] [Related]
19. [Expression of proliferation marker Ki 67 in chronic lymphocytic leukemia]. Diop S; Letestu R; Orsolani D; Leboeuf Y; Le Tutour P; Thiam D; Diakhate L; Valensi F Dakar Med; 2005; 50(2):65-8. PubMed ID: 16295759 [TBL] [Abstract][Full Text] [Related]
20. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies. Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]